Homeostatic regulation of perisynaptic matrix metalloproteinase 9 (MMP9) activity in the amblyopic visual cortex

Sachiko Murase1,2, Dan Winkowski1,2, Ji Liu1,2

  • 1Department of Biology, University of Maryland, College Park, United States.

Elife
|December 24, 2019
PubMed

Insights

Light reintroduction reactivates synaptic plasticity in amblyopic mice by activating MMP2/9 proteolysis. Dark exposure lowers the activation threshold, enabling recovery from amblyopia.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Visual System Research

Background:

  • Dark exposure (DE) followed by light reintroduction (LRx) enhances synaptic plasticity in the adult mouse primary visual cortex (V1).
  • Matrix metalloproteinase 9 (MMP9) mediates plasticity enhancement by LRx in binocular mice.
  • The role of this pathway in amblyopic visual systems was previously unknown.

Purpose of the Study:

  • To investigate if the visual system of amblyopic adult mice can engage the MMP9 pathway.
  • To determine the role of MMP2/9 activity and extracellular matrix (ECM) degradation in amblyopic V1 following LRx.
  • To explore how visual experience history and DE affect MMP2/9 activity.

Main Methods:

  • Administering LRx to adult amblyopic mice.
  • Assessing perisynaptic MMP2/9 activity and ECM degradation in V1.
  • Using two-photon live imaging to observe MMP2/9 activity dynamics.
  • Restricting LRx to the amblyopic eye to assess pathway specificity.

Main Results:

  • LRx in adult amblyopic mice induced perisynaptic MMP2/9 activity and ECM degradation in both deprived and non-deprived V1.
  • LRx to the amblyopic eye alone triggered significant MMP2/9 activity and ECM degradation in deprived V1.
  • Visual experience history regulates MMP2/9 activity, with DE lowering the activation threshold.
  • DE facilitates MMP2/9 activation by visual input from the amblyopic pathway.

Conclusions:

  • The MMP2/9 pathway is engaged in adult amblyopic mice following LRx, contributing to synaptic plasticity.
  • DE plays a crucial homeostatic role by reducing the MMP2/9 activation threshold, enabling recovery from amblyopia.
  • Targeting MMP2/9 activity presents a potential therapeutic strategy for amblyopia treatment.